Merck & Company Inc (MRK)vsPalatin Technologies, Inc. Common Stock (PTN)
MRK
Merck & Company Inc
$141.16
-0.63%
HEALTHCARE · Cap: $360.08B
PTN
Palatin Technologies, Inc. Common Stock
$5.10
+6.92%
HEALTHCARE · Cap: $9.10M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 504784% more annual revenue ($66.57B vs $13.19M). MRK leads profitability with a 4.8% profit margin vs -63.5%. PTN appears more attractively valued with a PEG of 1.62. PTN earns a higher WallStSmart Score of 39/100 (F).
MRK
Hold36
out of 100
Grade: F
PTN
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-73.7%
Fair Value
$83.64
Current Price
$141.16
$57.52 premium
Intrinsic value data unavailable for PTN.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
Trading at 8.3x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Expensive relative to growth rate
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -297.2% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : PTN
The strongest argument for PTN centers on Price/Book, Debt/Equity.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 115.8x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : PTN
The primary concerns for PTN are PEG Ratio, EPS Growth, Market Cap.
Key Dynamics to Monitor
MRK profiles as a value stock while PTN is a turnaround play — different risk/reward profiles.
MRK carries more volatility with a beta of 0.22 — expect wider price swings.
MRK is growing revenue faster at 5.1% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Bottom Line
PTN scores higher overall (39/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Palatin Technologies, Inc. Common Stock
HEALTHCARE · BIOTECHNOLOGY · USA
Palatin Technologies, Inc., a specialty biopharmaceutical company, develops targeted receptor-specific therapies for the treatment of various diseases in the United States. The company is headquartered in Cranbury, New Jersey.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?